TURANO, Raffaele
 Distribuzione geografica
Continente #
NA - Nord America 479
EU - Europa 311
AS - Asia 79
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 871
Nazione #
US - Stati Uniti d'America 477
PL - Polonia 150
CN - Cina 62
DE - Germania 45
UA - Ucraina 45
IT - Italia 22
IN - India 10
FI - Finlandia 9
GB - Regno Unito 9
FR - Francia 8
IE - Irlanda 7
BE - Belgio 6
RU - Federazione Russa 5
SE - Svezia 5
VN - Vietnam 4
CA - Canada 2
HK - Hong Kong 2
AU - Australia 1
EU - Europa 1
TR - Turchia 1
Totale 871
Città #
Warsaw 150
Fairfield 85
Chandler 50
Woodbridge 43
Jacksonville 35
Ashburn 31
Houston 31
Cambridge 30
Seattle 25
Wilmington 25
Ann Arbor 22
Beijing 14
Princeton 14
Milan 12
Hebei 9
New York 8
Brescia 7
Dublin 7
Nanchang 7
Pune 7
Brussels 6
Dearborn 6
Helsinki 6
Shenyang 6
Nanjing 5
Dong Ket 4
Des Moines 3
Hangzhou 3
Jiaxing 3
London 3
San Diego 3
Shanghai 3
Tianjin 3
Hong Kong 2
Ningbo 2
Zhengzhou 2
Augusta 1
Boardman 1
Brooklyn 1
Buffalo 1
Changsha 1
Chicago 1
Council Bluffs 1
Falkenstein 1
Frankfurt 1
Frankfurt am Main 1
Haikou 1
Hounslow 1
Jersey City 1
Jinan 1
Kocaeli 1
Los Angeles 1
Melbourne 1
Monmouth Junction 1
North York 1
Norwalk 1
Nürnberg 1
Orange 1
Padova 1
Phoenix 1
Prescot 1
Redwood City 1
San Francisco 1
Sarezzo 1
Taiyuan 1
Taizhou 1
Toronto 1
Verona 1
Walnut 1
Yellow Springs 1
Totale 706
Nome #
Acute Dacryocystitis with Empyema of the Lacrimal Sac: Is Immediate Endoscopic Dacryocystorhinostomy Justified? 361
Arteriolar Diameters in Glaucomatous Eyes with Single-Hemifield Damage 135
Reduction of vitreous prostaglandin E2 Levels after topical administration of Indomethacin 0.5%, Bromfenac 0.09%, and Nepafenac 0.1% 113
Comparison of smartphone ophthalmoscopy with slit-lamp biomicroscopy for grading vertical cup-to-disc ratio 107
Vitreous Nonsteroidal Anti-Inflammatory Drug Levels in Vitrectomy Patients Treated with Topical Indomethacin 0.5\%, Nepafenac 0.1\%, and Bromfenac 0.09\% 71
Functional and Morphological Changes Following Macular Pucker Surgery After Topical Administration of Indomethacin 0.5%, Bromfenac 0.09%, Nepafenac 0.1%, or Placebo 64
Twelve-month results of treatment with intravitreal ranibizumab, intravitreal ranibizumab plus ketorolac eye drops, and intravitreal ranibizumab plus low-fluence photodynamic therapy for exudative age-related macular degeneration 57
Totale 908
Categoria #
all - tutte 2.967
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.967


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201949 0 0 0 0 0 0 0 0 0 0 25 24
2019/2020238 26 9 11 22 16 28 19 27 23 33 13 11
2020/2021158 4 14 3 14 33 28 2 16 10 16 8 10
2021/202279 3 5 2 8 2 9 0 8 2 19 9 12
2022/202399 9 6 3 15 10 23 0 9 14 2 3 5
2023/202451 7 0 7 7 4 16 2 4 3 1 0 0
Totale 908